Valuation: NOVARTIS

Market Cap 302B 259B 242B 222B 416B 28,911B 422B 2,861B 1,116B 14,524B 1,135B 1,110B 48,038B P/E 2026 *
22.6x
P/E 2027 * 19.3x
Enterprise Value 335B 287B 268B 246B 461B 32,038B 467B 3,171B 1,237B 16,094B 1,257B 1,230B 53,233B EV / Sales 2026 *
5.81x
EV / Sales 2027 * 5.38x
Free-Float
91.66%
Yield 2026 *
2.75%
Yield 2027 * 2.87%
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Compliance Officer 58 2025-04-13
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+6.38%+76.40%+126.87% 1,119B
+1.07%+3.80%+50.73%+64.25% 651B
+1.20%+6.21%+25.81%+80.15% 468B
-1.41%+3.99%+42.48%+42.34% 374B
-0.78%+2.46%+24.89%+40.71% 302B
-1.23%+4.58%+1.84%+12.47% 259B
+1.29%+5.81%+49.57%+70.71% 238B
-0.03%+2.96%-18.04%-53.38% 208B
+1.87%+5.61%+27.32%+89.67% 181B
Average +0.04%+5.17%+31.22%+52.64% 422.21B
Weighted average by Cap. +0.02%+5.40%+44.07%+72.28%

Financials

2026 *2027 *
Net sales 57.65B 49.38B 46.21B 42.3B 79.38B 5,516B 80.43B 546B 213B 2,771B 216B 212B 9,165B 61.31B 52.52B 49.14B 44.98B 84.42B 5,866B 85.53B 581B 226B 2,947B 230B 225B 9,747B
Net income 13.95B 11.95B 11.18B 10.24B 19.21B 1,335B 19.46B 132B 51.52B 671B 52.38B 51.24B 2,218B 15.5B 13.28B 12.42B 11.37B 21.34B 1,483B 21.63B 147B 57.25B 745B 58.21B 56.94B 2,464B
Net Debt 32.68B 27.99B 26.19B 23.98B 45B 3,127B 45.59B 309B 121B 1,571B 123B 120B 5,195B 27.82B 23.83B 22.3B 20.41B 38.3B 2,662B 38.81B 263B 103B 1,337B 104B 102B 4,422B
Logo NOVARTIS
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA